DMT is the major psychoactive compound in ayahuasca, a drink made from vines The effects of a powerful psychedelic drug are similar to a near-death experience, research suggests. Answers to a ...

By contrast, DMT exhibits a comparatively more rapid onset ... harness artificial intelligence (AI), ‘big data’ and small-molecule therapy (SMT). For example, atai’s drug-development ...

Cybin is also developing CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder. It reports that the phase 2 results of its CYB004 anxiety treatment drug study are set for ...

One goal of the company is to optimize the pharmacokinetics and bioavailability of DMT, as the molecule itself is quickly metabolized. Small Pharma is researching DMT analogues, replacing specific ...

It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized ...

A number of pharmaceutical companies are experimenting on creating the next generation of psychedelic drugs with the goal of ...

A group of chemistry, metabolism and diabetes researchers from Aarhus University has now created a molecule that can induce the same metabolic effects, without physical exertion or fasting.

Water molecules are so attracted to each other that even after the balloon pops, the water molecules stay together keeping the shape of the balloon. In the water molecule, the oxygen and hydrogen ...

The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for ...

The presentation titled, “Non-hallucinogenic and neuroplastogenic DMT analog imparts positive ... development of novel neuroplastogenic small-molecule therapeutics for the treatment of ...